Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)
China flag China · Delayed Price · Currency is CNY
25.70
-0.47 (-1.80%)
At close: Nov 13, 2026

SHE:301290 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
74.47-37.9497.4297.22102.51110.25
Depreciation & Amortization
41.4141.642.7339.3536.3729.89
Other Amortization
0.620.430.170.711.11
Loss (Gain) From Sale of Assets
0.030.030.090.590.430.25
Asset Writedown & Restructuring Costs
105.36105.36---0.76
Loss (Gain) From Sale of Investments
-28.13-28.13-29.06-19.32-2.85-2.22
Provision & Write-off of Bad Debts
-0.74-0.740.44-0.452.88-
Other Operating Activities
-98.982.58-1.420.470.41.08
Change in Accounts Receivable
18.6118.610.2638.64-46.7339.53
Change in Inventory
-5.37-5.37-9.07-1.46-7.44-5.9
Change in Accounts Payable
-9.86-9.8627.344.3611.37-7.77
Change in Other Net Operating Assets
0.390.392.251.47-1.4-
Operating Cash Flow
94.9484.09126.49163.1394.63163.45
Operating Cash Flow Growth
6.44%-33.52%-22.46%72.39%-42.10%43.29%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-58.56-46.06-115.96-111.46-74.35-95.67
Sale of Property, Plant & Equipment
0.050.070.140.230.220.28
Cash Acquisitions
-528.27---2.69--39.82
Investment in Securities
226.14-126.69-424.4-530.85-68.72-6.8
Other Investing Activities
26.2325.6336.934.424.64-0.08
Investing Cash Flow
-334.4-147.05-503.29-640.35-138.2-142.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-144.4545.773.2--
Total Debt Issued
488.48144.4545.773.2--
Short-Term Debt Repaid
--61.56-14.94-1--
Long-Term Debt Repaid
--0.61-0.52-1.4-2.34-2.48
Lease Payments
-0.61-0.61-0.52-1.4-2.34-2.48
Total Debt Repaid
-155.82-62.17-15.46-2.4-2.34-2.48
Net Debt Issued (Repaid)
332.6582.2830.310.8-2.34-2.48
Issuance of Common Stock
----1,029-
Repurchase of Common Stock
---29.99---
Common Dividends Paid
-32.24-60.42-59.59-50.09--
Dividends Paid
-32.24-60.42-59.59-50.09--
Other Financing Activities
-18.562.25-11.27-19.98-7.84-4.1
Financing Cash Flow
281.8624.11-70.54-69.271,019-6.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.69-0.51-0.150.10.47-0.15
Net Cash Flow
41.72-39.37-447.48-546.39975.4714.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
36.3938.0310.5451.6820.2867.78
Free Cash Flow Growth
17.09%260.93%-79.61%154.83%-70.08%-23.54%
Free Cash Flow Margin
8.39%9.81%2.42%11.91%4.59%15.18%
Free Cash Flow Per Share
0.370.380.110.520.260.90
Levered Free Cash Flow
-21.266.2815.5-19.1113.16-2.49
Unlevered Free Cash Flow
-217.0715.71-19.0713.24-2.42
Free Cash Flow After Leases
35.7837.4210.0250.2817.9365.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
49.4249.1843.7360.6637.7151.46
Change in Working Capital
0.90.916.1344.58-46.122.33